Improved Cryptosporidium parvum oocyst propagation using dexamethasone suppressed CF-1 mice

Veterinary Parasitology

Volumn 168, Issue 3-4, 2010, Pages 329-331

  Ware, Michael W ^a   Villegas, Eric N ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

C57BL 6; CF 1; Cryptosporidium parvum; Immunosuppression; Mouse; Oocysts

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; TETRACYCLINE;

ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CF 1 MOUSE; COST EFFECTIVENESS ANALYSIS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; MOUSE; MOUSE STRAIN; NONHUMAN; OOCYST; SURVIVAL RATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CRYPTOSPORIDIUM PARVUM; DEXAMETHASONE; IMMUNOSUPPRESSION; MICE; MICE, INBRED C57BL; OOCYSTS; PARASITOLOGY;

CRYPTOSPORIDIUM PARVUM; MURINAE; MUS;

EID: 77349093023     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.11.019     Document Type: Article

References (12)

1. Arrowood M.J., and Donaldson K. Improved purification methods for calf-derived Cryptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients. J. Eukaryot. Microbiol. 43 (1996) 89S
2. Arrowood M.J., and Sterling C.R. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J. Parasitol. 73 (1987) 314-319
3. Baker B. Fundemental Skills in Hematology (1980), Charles C. Thomas, Springfield, IL p. 497
4. Brasseur P., Lemeteil D., and Ballet J.J. Rat model for human cryptosporidiosis. J. Clin. Microbiol. 26 (1988) 1037-1039
5. Cicmanec J.L., and Reasoner D.J. Enhanced production of Cryptosporidium parvum oocysts in immunosuppressed mice. In: Fricker C.R., Clancy J.L., and Rochelle P.A. (Eds). International Symposium on Waterborne Cryptosporidium Proceedings (1997), American Water Works Assoc., Denver, CO 127-131
6. Girouard D., Gallant J., Akiyoshi D.E., Nunnari J., and Tzipori S. Failure to propagate Cryptosporidium spp. in cell-free culture. J. Parasitol. 92 (2006) 399-400
7. Hijjawi N.S., Meloni B.P., Ng'anzo M., Ryan U.M., Olson M.E., Cox P.T., Monis P.T., and Thompson R.C. Complete development of Cryptosporidium parvum in host cell-free culture. Int. J. Parasitol. 34 (2004) 769-777
8. Miller T.A., and Schaefer III F.W. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum. Vet. Parasitol. 141 (2006) 66-83
9. Petry F., Robinson H.A., and McDonald V. Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts. J. Clin. Microbiol. 33 (1995) 1922-1924
10. Rasmussen K.R., and Healey M.C. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect. Immun. 60 (1992) 1648-1652
11. von Oettingen J., Nath-Chowdhury M., Ward B.J., Rodloff A.C., Arrowood M.J., and Ndao M. High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice. Parasitology 135 (2008) 1151-1156
12. Yang S., Benson S.K., Du C., and Healey M.C. Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum. J. Parasitol. 86 (2000) 884-887